Sartore‐Bianchi described the identification of a novel LMNA‐NTRK1 gene fusion in a metastatic CRC patient, which was linked to sensitivity to the pan‐TRK inhibitor, entrectinib. The gene discussed is NTRK1; the disease is colorectal carcinoma.